Olso University Hospital, Institute of Cancer Research, Oslo, Norway. Search for other works by this author on: ...

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight 2025” report provides comprehensive insights about 150+ ...

Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...

Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting ...

Throwing a 'Spanner in the Works' of Our Cells' Machinery Could Help Fight Cancer, Fatty Liver Disease... and Hair Loss Apr. 18, 2025 — Fifty years since its discovery, scientists have finally ...

FGFR1-targeting Pemazyre was approved by the ... At the moment, FGFR2 and FGFR3 inhibitor Balversa is only FDA-approved for bladder cancer. Around 25,000 people in Japan are diagnosed with biliary ...

The annual cancer statistics report from the National Cancer Institute (NCI) — which was published in the journal Cancer on Monday, April 21 — shows some signs of progress in America’s fight ...

Patients with tumors in the trigone and urethra were more likely to experience recurrence and cancer-specific death after radical cystectomy than patients with tumor only in the bladder walls.

Changchun GeneScience Pharmaceutical Co., Ltd., Shanghai, China.

A Possible Shift in Cancer Care This steam-based treatment represents more than a new tool—it’s part of a shift toward personalized, less invasive cancer care.Instead of removing or damaging ...

An international research team led by a Boston College professor has uncovered a drug and diet pairing that could fight a deadly brain cancer The international team combined a calorie-restricted diet ...

2025 年第 116 届 AACR 年会将于 2025 年 4 月 25 日 - 30 日 在美国芝加哥市麦考密克会展中心召开 (点击此处查看会议日程安排https://www.aacr.org/meeting/aacr-annual-meeting-2025/schedule-at-a-glance/)。